Karachi, Citi Pharma Ltd., a newer entrant to the Pakistan Stock Exchange since 2021, has announced its financial results. The company's share price was reported at Rs. 21.28, closely matching its daily weighted average rate of Rs. 21.26. Citi Pharma Ltd. has a paid-up capital of Rs. 2,284.61 million. Despite declaring no dividend, the company reported a 25% bonus distribution for the financial year 2022/2023. The EPS for the year stood at Rs. 2.88.